Design of liposomes as drug delivery system for therapeutic applications

被引:608
|
作者
Guimaraes, Diana [1 ]
Cavaco-Paulo, Artur [1 ,2 ]
Nogueira, Eugenia [1 ,2 ]
机构
[1] Univ Minho, Ctr Biol Engn, Braga, Portugal
[2] Solfarcos Pharmaceut & Cosmet Solut, Braga, Portugal
基金
欧盟地平线“2020”;
关键词
Liposomes; Drug delivery; Liposome production; Liposome characterization; Market liposomes; NANOPARTICLE TRACKING ANALYSIS; ENCAPSULATION EFFICIENCY; CANCER-THERAPY; PHOSPHOLIPIDS; GENERATION; FLUORESCENT; EXPERIENCE; CHALLENGES; STRATEGIES; STABILITY;
D O I
10.1016/j.ijpharm.2021.120571
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Liposomes are spherical vesicles consisting of one or more concentric phospholipid bilayers enclosing an aqueous core. Being both nontoxic and biodegradable, liposomes represent a powerful delivery system for several drugs. They have improved the therapeutic efficacy of drugs through stabilizing compounds, overcoming obstacles to cellular and tissue uptake and increasing drug biodistribution to target sites in vivo, while minimizing systemic toxicity. This review offers an overview of liposomes, thought the exploration of their key fundamentals. Initially, the main design aspects to obtain a successful liposomal formulation were addressed, following the techniques for liposome production and drug loading. Before application, liposomes required an extensive characterization to assurance in vitro and in vivo performance. Thus, several properties to characterize liposomes were explored, such as size, polydispersity index, zeta potential, shape, lamellarity, phase behavior, encapsulation efficiency, and in vitro drug release. Topics related with liposomal functionalization and effective targeting strategies were also addressed, as well as stability and some limitations of liposomes. Finally, this review intends to explore the current market liposomes used as a drug delivery system in different therapeutic applications.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Development of intracellular drug delivery system using fusogenic liposomes
    Yoshikawa, Tomoaki
    Okada, Naoki
    Nakagawaa, Shinsaku
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (05): : 789 - 796
  • [42] Liposomes as drug delivery systems
    Clark, AP
    CANCER PRACTICE, 1998, 6 (04) : 251 - 253
  • [43] Bioadhesive liposomes bearing levonorgestrel as controlled drug delivery system
    Uppadhyay, AK
    Dixit, VK
    PHARMAZIE, 1998, 53 (06): : 421 - 422
  • [44] Liposomes - Opportunities in drug delivery
    Allen, TM
    DRUGS, 1997, 54 (Suppl 4) : 8 - 14
  • [45] LIPOSOMES FOR THE DRUG DELIVERY OF CARBORANES
    Olusanya, Temidayo
    NEURO-ONCOLOGY, 2013, 15 : 61 - 61
  • [46] Liposomes for drug delivery in stroke
    Bruch, Gisele E.
    Fernandes, Lorena F.
    Bassi, Beatriz L. T.
    Alves, Marco Tullio R.
    Pereira, Isabelle O.
    Frezard, Frederic
    Massensini, Andre R.
    BRAIN RESEARCH BULLETIN, 2019, 152 : 246 - 256
  • [47] DRUG DELIVERY USING LIPOSOMES
    ASSERAF, P
    GAZETTE MEDICALE, 1990, 97 (28): : 11 - 15
  • [48] Characterizing Liposomes for Drug Delivery
    Carnell, Pauline
    Kaszuba, Mike
    R&D MAGAZINE, 2014, 56 (02): : 16 - 17
  • [49] Study of ocular drug delivery system using drug-loaded liposomes
    Jain, Roonal L.
    Shastri, J. P.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2011, 1 (01) : 35 - 41
  • [50] LIPOSOMES IN TOPICAL DRUG DELIVERY
    SCHAEFFER, HE
    KROHN, DL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1982, 22 (02) : 220 - 227